RxDoctor Payments Data

Troy Shepherd, DPM

Foot & Ankle Surgery · Alamogordo, NMNPI 1376898437

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Smith+Nephew at 35.7% of the total. Reporting peaked in 2021 at $359 and has fallen 84.9% since, to $54 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NM, where the typical reported total is $2,589.

$910in general payments, 2019–2025

Across 42 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$325
  • Abbott$213
  • Reapplix Inc.$160
  • Boston Scientific$109
  • Tactile Systems Technology Inc$28
  • Organogenesis Inc.$26
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$910100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$910 in reported general payments places this provider in the 30th percentile of 69 foot & ankle surgery providers in New Mexico.

See all foot & ankle surgery providers in New Mexico

Medicare billing

Part B allowed, 2024
$346,908
Medicare patients
516
Services billed
3,170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip373$9,773
Ciclopirox125$3,555
Cephalexin110$2,076
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav65$1,257
Mupirocin117$1,151
Terbinafine Hcl61$565
Levofloxacin13$440
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim44$412
Celecoxib21$273
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$224
Doxycycline Hyclate17$174
Gabapentin17$172
Ondansetron Hcl20$139

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Alamogordo

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →